0000950170-24-025915.txt : 20240305 0000950170-24-025915.hdr.sgml : 20240305 20240305161211 ACCESSION NUMBER: 0000950170-24-025915 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240302 FILED AS OF DATE: 20240305 DATE AS OF CHANGE: 20240305 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lamothe Jeffrey G. CENTRAL INDEX KEY: 0001679967 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37746 FILM NUMBER: 24720478 MAIL ADDRESS: STREET 1: 2401 4TH AVENUE STREET 2: SUITE 1050 CITY: SEATTLE STATE: WA ZIP: 98121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aptevo Therapeutics Inc. CENTRAL INDEX KEY: 0001671584 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 811567056 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2401 4TH AVE. STREET 2: SUITE 1050 CITY: SEATTLE STATE: WA ZIP: 98121 BUSINESS PHONE: 206-838-0500 MAIL ADDRESS: STREET 1: 2401 4TH AVE. STREET 2: SUITE 1050 CITY: SEATTLE STATE: WA ZIP: 98121 4 1 ownership.xml 4 X0508 4 2024-03-02 0001671584 Aptevo Therapeutics Inc. APVO 0001679967 Lamothe Jeffrey G. 2401 4TH AVENUE SUITE 1050 SEATTLE WA 98121 false true false false EVP, COO false Common Stock 2024-03-02 4 M false 5500 A 33837 D Common Stock 2024-03-03 4 M false 3667 A 37504 D Restricted Stock Unit 2024-03-02 4 M false 5500 0 D Common Stock 5500 11000 D Restricted Stock Unit 2024-03-03 4 M false 3667 0 D Common Stock 3667 3667 D Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis. On March 3, 2023, the reporting person was granted 16,500 RSUs, vesting in three approximately equal annual installments beginning on March 2, 2024. On June 7, 2022, the reporting person was granted 11,000 RSUs, vesting in three approximately equal annual installments beginning on March 3, 2023. /s/ SoYoung Kwon, Attorney-in-Fact 2024-03-05